Bio-Techne (TECH) revenue was $1.2B in FY2026 (-0% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2026
$1.2B
-0%
2025
$1.2B
+5%
2024
$1.2B
+2%
2023
$1.1B
+3%
2022
$1.1B
+19%
2021
$931M
+26%
2020
$739M
+3%
2019
$714M
+11%
2018
$643M
+14%
2017
$563M
+13%
2016
$499M
+10%
2015
$452M
+26%
2014
$358M
+15%
2013
$311M
-1%
2012
$315M
+8%
2011
$290M
+8%
2010
$269M
+2%
2009
$264M
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$321M
Q1 2026
$311M
Q4 2025
$296M
Q3 2025
$287M
Q2 2025
$317M
Q1 2025
$316M
Q4 2024
$297M
Q3 2024
$289M
Q2 2024
$306M
Q1 2024
$303M
Q4 2023
$273M
Q3 2023
$277M
Source: TECH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.